title: The decision to use succinylcholine for critically ill patients should not be based on duration of time in the intensive care unit alone.
authors.affiliation: Department of Anesthesia, Critical Care and Pain MedicineMassachusetts General HospitalBoston, Massachusettsebittner@partners.org Professor EmeritusDepatment of AnesthesiologyUniversity of California DavisDavis, California.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Bittner
authors.forename: J A Jeevendra
authors.initials: JAJ
authors.lastname: Martyn
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Gronert
mesh_terms: D003422:Critical Care; D016638:Critical Illness / Q000628:therapy*; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use*; D013390:Succinylcholine / Q000627:therapeutic use*
chemical_list: D009466:Neuromuscular Blocking Agents; D013390:Succinylcholine